|
1）Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 2013; 12: 1180-8
|
|
|
|
2）Hafer-Macko CE, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol. 1996; 39: 625-35
|
|
|
|
|
|
3）Devaux JJ, Odaka M, Yuki N. Nodal proteins are target antigens in Guillain-Barré syndrome. J Peripher Nerv Syst. 2012; 17: 62-71
|
|
|
|
|
|
4）Ng JK, Malotka J, Kawakami N, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 2012; 79: 2241-8
|
|
|
|
|
|
5）Sawai S, Satoh M, Mori M, et al. Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome. Neurology. 2014; 83: 113-7
|
|
|
|
|
|
6）Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 2014; 82: 879-86
|
|
|
|
|
|
7）Kawamura N, Yamasaki R, Yonekawa T, et al. Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology. 2013; 81: 714-22
|
|
|
|
|
|
8）Miura Y, Devaux JJ, Fukami Y, et al. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain. 2015; 138: 1484-91
|
|
|
|
|
|
9）Willison H, Scherer SS. Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis. Neurology. 2014; 83: 106-8
|
|
|
|
|
|
10）Iontcheva I, Amar S, Zawawi KH, et al. Role for moesin in lipopolysaccharide-stimulated signal transduction. Infect Immun. 2004; 72: 2312-20
|
|
|
|
|
|
11）Miyaji K, Shahrizaila N, Umapathi T, et al. Are ERM (ezrin/radixin/moesin)proteins targets for autoantibodies in demyelinating neuropathies? Hum Immunol. 2014; 75: 1089-91
|
|
|
|
|